This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Mar 19;387(10024):1141-3.

doi: 10.1016/S0140-6736(16)00699-1.

Why are people living with HIV still dying of tuberculosis?

Peter Godfrey-Faussett¹, Helen Ayles²

Affiliations

Affiliations

¹ Office of the Deputy Executive Director, UNAIDS, Geneva, Switzerland; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK. Electronic address: faussettp@unaids.org.
² ZAMBART, Lusaka, Zambia; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.

PMID: 27025319
DOI: 10.1016/S0140-6736(16)00699-1

Free article

Comment

Why are people living with HIV still dying of tuberculosis?

Peter Godfrey-Faussett et al. Lancet. 2016.

Free article

. 2016 Mar 19;387(10024):1141-3.

doi: 10.1016/S0140-6736(16)00699-1.

Authors

Peter Godfrey-Faussett¹, Helen Ayles²

Affiliations

¹ Office of the Deputy Executive Director, UNAIDS, Geneva, Switzerland; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK. Electronic address: faussettp@unaids.org.
² ZAMBART, Lusaka, Zambia; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.

PMID: 27025319
DOI: 10.1016/S0140-6736(16)00699-1

No abstract available

PubMed Disclaimer

Comment on

Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.
Hosseinipour MC, Bisson GP, Miyahara S, Sun X, Moses A, Riviere C, Kirui FK, Badal-Faesen S, Lagat D, Nyirenda M, Naidoo K, Hakim J, Mugyenyi P, Henostroza G, Leger PD, Lama JR, Mohapi L, Alave J, Mave V, Veloso VG, Pillay S, Kumarasamy N, Bao J, Hogg E, Jones L, Zolopa A, Kumwenda J, Gupta A; Adult AIDS Clinical Trials Group A5274 (REMEMBER) Study Team. Hosseinipour MC, et al. Lancet. 2016 Mar 19;387(10024):1198-209. doi: 10.1016/S0140-6736(16)00546-8. Lancet. 2016. PMID: 27025337 Free PMC article. Clinical Trial.

Similar articles

The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting.
Frigati LJ, Kranzer K, Cotton MF, Schaaf HS, Lombard CJ, Zar HJ. Frigati LJ, et al. Thorax. 2011 Jun;66(6):496-501. doi: 10.1136/thx.2010.156752. Epub 2011 Apr 2. Thorax. 2011. PMID: 21460373 Clinical Trial.
Isoniazid prophylaxis against tuberculosis in children.
Zar HJ, Lombard C. Zar HJ, et al. N Engl J Med. 2011 Oct 20;365(16):1543; author reply 1543-4. doi: 10.1056/NEJMc1109603. N Engl J Med. 2011. PMID: 22010924 No abstract available.
Preventive therapy against tuberculosis in people living with HIV.
[No authors listed] [No authors listed] Wkly Epidemiol Rec. 1999 Nov 19;74(46):385-98. Wkly Epidemiol Rec. 1999. PMID: 10611855 English, French. No abstract available.
Tuberculosis preventive therapy for HIV-infected persons in less developed countries.
Kritski AL. Kritski AL. Int J Tuberc Lung Dis. 2000 Feb;4(2 Suppl 1):S76-81. Int J Tuberc Lung Dis. 2000. PMID: 10688154 Review. No abstract available.
Prophylaxis for tuberculosis in Europe--ongoing research.
Carosi G, Matteelli A. Carosi G, et al. Clin Infect Dis. 1996 Apr;22 Suppl 1:S55-60. doi: 10.1093/clinids/22.supplement_1.s55. Clin Infect Dis. 1996. PMID: 8785258 Review.

See all similar articles

Cited by

Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort study.
Gupta-Wright A, Corbett EL, Wilson D, van Oosterhout JJ, Dheda K, Huerga H, Peter J, Bonnet M, Alufandika-Moyo M, Grint D, Lawn SD, Fielding K. Gupta-Wright A, et al. PLoS Med. 2019 Apr 5;16(4):e1002776. doi: 10.1371/journal.pmed.1002776. eCollection 2019 Apr. PLoS Med. 2019. PMID: 30951533 Free PMC article.
The Effect of International Travel Arrivals on the New HIV Infections in 15-49 Years Aged Group Among 109 Countries or Territories From 2000 to 2018.
Du M, Yuan J, Jing W, Liu M, Liu J. Du M, et al. Front Public Health. 2022 Feb 16;10:833551. doi: 10.3389/fpubh.2022.833551. eCollection 2022. Front Public Health. 2022. PMID: 35252102 Free PMC article.
Global, regional, and national disease burden and attributable risk factors of HIV/AIDS in older adults aged 70 years and above: a trend analysis based on the Global Burden of Disease study 2019.
Du M, Liu M, Liu J. Du M, et al. Epidemiol Infect. 2023 Dec 15;152:e2. doi: 10.1017/S0950268823001954. Epidemiol Infect. 2023. PMID: 38097398 Free PMC article.
An Anthropocentric View of the Virosphere-Host Relationship.
Rodrigues RAL, Andrade ACDSP, Boratto PVM, Trindade GS, Kroon EG, Abrahão JS. Rodrigues RAL, et al. Front Microbiol. 2017 Aug 30;8:1673. doi: 10.3389/fmicb.2017.01673. eCollection 2017. Front Microbiol. 2017. PMID: 28912772 Free PMC article.
High rates of exposure to tuberculosis patients among HIV-infected health care workers in Botswana.
Shin SS, Modongo C, Zetola NM, Wang Q, Phologolo T, Kestler M, Ho-Foster A. Shin SS, et al. Int J Tuberc Lung Dis. 2018 Apr 1;22(4):366-370. doi: 10.5588/ijtld.17.0376. Int J Tuberc Lung Dis. 2018. PMID: 29562982 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information